Even bullish markets don't excite skittish consumers who worry that quality may be traded for profit. How much is this perception reinforced when once-thriving stock declines, as has happened to some large, publicly traded HMOs recently?
The total stock value of the HMO industry grew 13-fold between January 1987 and November 1997, according to the Henry J. Kaiser Family Foundation. Compare that with the growth of the stock market as a whole during the same period, “only” four-fold, and you can see why investors jumped aboard. Still, there's that nagging fear that what goes up…. Several large publicly traded HMOs lost market value in 1997.
The question persists: Are the dual goals of pleasing shareholders and delivering high quality health care contradictory? We can't answer that, but we can report what consumers told the foundation in a survey earlier this year.
SOURCE: SURVEY OF AMERICANS ABOUT HEALTH CARE AND THE STOCK MARKET, KAISER FAMILY FOUNDATION, MENLO PARK, CALIF., 1998
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweißen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.